FDA Inspection 1210478 - Gland Pharma Limited, Units I+II Pashamylaram Site - June 27, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on June 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: June 27, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · cdefda8a-9fac-4c48-90f1-47b5c117ec07